Contents
pdf Download PDF pdf Download XML
969 Views
1501 Downloads
Share this article
Research Article | Volume 17 Issue 1 (Jan-Dec, 2024) | Pages 53 - 56
A Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Colchicine versus Oral Isotretinoin in the Treatment of Lichen Planus Pigmentosus
1
Assistant ProfessorDept. of DVL, Amaltas Institute of Medical Sciences, Dewas, M.P
Under a Creative Commons license
Open Access
Received
Feb. 21, 2024
Revised
March 5, 2024
Accepted
March 16, 2024
Published
March 22, 2024
Abstract

Background & Methods: The aim of the study is to study Randomized Controlled Trial Comparing the Efficacy & Safety of Oral Colchicine versus Oral Isotretinoin in the Treatment of Lichen Planus Pigmentosus. Lichen Planus Pigmentosus (LPP) is a chronic pigmentary disorder with limited therapeutic options. Oral isotretinoin & colchicine have been reported to have beneficial effects, but head-to-head comparisons are lacking.

Results: Both groups showed significant improvement in pigmentation. The colchicine group showed a higher rate of marked improvement (≥75% reduction in pigmentation score) compared to isotretinoin (48% vs. 32%, p = 0.04). Adverse effects were mild in both groups, though mucocutaneous dryness was more frequent in the isotretinoin group.

Conclusion: Oral colchicine is a safe & more effective alternative to isotretinoin in treating LPP.

Keywords
Recommended Articles
Research Article
Coexistence of Psoriasis and Alopecia Universalis: A Rare Clinical Association
...
Published: 26/09/2026
Research Article
WNT-activated deep penetrating melanocytoma arising within a congenital melanocytic nevus in a pediatric patient: a case report
...
Published: 26/09/2026
Case Report
Pellagra-like presentation of borderline tuberculoid Hansen disease with a Type 1 lepra reaction: a diagnostic mimic
Published: 18/09/2026
Research Article
Analgesic Efficacy of Pericapsular Nerve Group Block versus Femoral Nerve Block before Spinal Anaesthesia for Hip Surgery: A Randomized Trial
Published: 08/08/2024
© Copyright Spejalisci Dermatolodzy